(Q24242725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

title

Antiplatelet therapy for acute ischaemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Carl Counsell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Gordon J Gubitz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Mei-Chiun Tseng

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

16 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

CD000029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Aspirin in the prevention of progressing stroke: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Aspirin to prevent heart attack and stroke: what's the right dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Complications after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Randomisation to protect against selection bias in healthcare trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Piracetam for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Guidelines for the Early Management of Adults With Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Evidence for episodic platelet activation in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Platelet activation and lipid peroxidation in patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Antiplatelet therapy for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

European Stroke Initiative Recommendations for Stroke Management – Update 2003

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Effect of therapy on platelet activating factor-induced aggregation in acute stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB2

7 January 2021

10.1002/14651858.CD000029.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2265404

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646056%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

11 January 2020

2265404

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2265404

1 reference